The Hypoxia-Adenosine Link during Myocardial Ischemia—Reperfusion Injury

Despite increasing availability and more successful interventional approaches to restore coronary reperfusion, myocardial ischemia-reperfusion injury is a substantial cause of morbidity and mortality worldwide. During myocardial ischemia, the myocardium becomes profoundly hypoxic, thus causing stabi...

Full description

Bibliographic Details
Main Authors: Wei Ruan, Xinxin Ma, In Hyuk Bang, Yafen Liang, Jochen Daniel Muehlschlegel, Kuang-Lei Tsai, Tingting W. Mills, Xiaoyi Yuan, Holger K. Eltzschig
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/8/1939
_version_ 1827618090723049472
author Wei Ruan
Xinxin Ma
In Hyuk Bang
Yafen Liang
Jochen Daniel Muehlschlegel
Kuang-Lei Tsai
Tingting W. Mills
Xiaoyi Yuan
Holger K. Eltzschig
author_facet Wei Ruan
Xinxin Ma
In Hyuk Bang
Yafen Liang
Jochen Daniel Muehlschlegel
Kuang-Lei Tsai
Tingting W. Mills
Xiaoyi Yuan
Holger K. Eltzschig
author_sort Wei Ruan
collection DOAJ
description Despite increasing availability and more successful interventional approaches to restore coronary reperfusion, myocardial ischemia-reperfusion injury is a substantial cause of morbidity and mortality worldwide. During myocardial ischemia, the myocardium becomes profoundly hypoxic, thus causing stabilization of hypoxia-inducible transcription factors (HIF). Stabilization of HIF leads to a transcriptional program that promotes adaptation to hypoxia and cellular survival. Transcriptional consequences of HIF stabilization include increases in extracellular production and signaling effects of adenosine. Extracellular adenosine functions as a signaling molecule via the activation of adenosine receptors. Several studies implicated adenosine signaling in cardioprotection, particularly through the activation of the Adora2a and Adora2b receptors. Adenosine receptor activation can lead to metabolic adaptation to enhance ischemia tolerance or dampen myocardial reperfusion injury via signaling events on immune cells. Many studies highlight that clinical strategies to target the hypoxia-adenosine link could be considered for clinical trials. This could be achieved by using pharmacologic HIF activators or by directly enhancing extracellular adenosine production or signaling as a therapy for patients with acute myocardial infarction, or undergoing cardiac surgery.
first_indexed 2024-03-09T10:00:42Z
format Article
id doaj.art-b695d39aec5348bea368b64e69c3b71e
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T10:00:42Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-b695d39aec5348bea368b64e69c3b71e2023-12-01T23:28:02ZengMDPI AGBiomedicines2227-90592022-08-01108193910.3390/biomedicines10081939The Hypoxia-Adenosine Link during Myocardial Ischemia—Reperfusion InjuryWei Ruan0Xinxin Ma1In Hyuk Bang2Yafen Liang3Jochen Daniel Muehlschlegel4Kuang-Lei Tsai5Tingting W. Mills6Xiaoyi Yuan7Holger K. Eltzschig8Department of Anesthesiology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USADepartment of Anesthesiology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USADepartment of Anesthesiology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USADepartment of Anesthesiology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USADepartment of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USADepartment of Biochemistry and Molecular Biology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USADepartment of Biochemistry and Molecular Biology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USADepartment of Anesthesiology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USADepartment of Anesthesiology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USADespite increasing availability and more successful interventional approaches to restore coronary reperfusion, myocardial ischemia-reperfusion injury is a substantial cause of morbidity and mortality worldwide. During myocardial ischemia, the myocardium becomes profoundly hypoxic, thus causing stabilization of hypoxia-inducible transcription factors (HIF). Stabilization of HIF leads to a transcriptional program that promotes adaptation to hypoxia and cellular survival. Transcriptional consequences of HIF stabilization include increases in extracellular production and signaling effects of adenosine. Extracellular adenosine functions as a signaling molecule via the activation of adenosine receptors. Several studies implicated adenosine signaling in cardioprotection, particularly through the activation of the Adora2a and Adora2b receptors. Adenosine receptor activation can lead to metabolic adaptation to enhance ischemia tolerance or dampen myocardial reperfusion injury via signaling events on immune cells. Many studies highlight that clinical strategies to target the hypoxia-adenosine link could be considered for clinical trials. This could be achieved by using pharmacologic HIF activators or by directly enhancing extracellular adenosine production or signaling as a therapy for patients with acute myocardial infarction, or undergoing cardiac surgery.https://www.mdpi.com/2227-9059/10/8/1939adenosinehypoxiaCD73CD39Adora2aA2A
spellingShingle Wei Ruan
Xinxin Ma
In Hyuk Bang
Yafen Liang
Jochen Daniel Muehlschlegel
Kuang-Lei Tsai
Tingting W. Mills
Xiaoyi Yuan
Holger K. Eltzschig
The Hypoxia-Adenosine Link during Myocardial Ischemia—Reperfusion Injury
Biomedicines
adenosine
hypoxia
CD73
CD39
Adora2a
A2A
title The Hypoxia-Adenosine Link during Myocardial Ischemia—Reperfusion Injury
title_full The Hypoxia-Adenosine Link during Myocardial Ischemia—Reperfusion Injury
title_fullStr The Hypoxia-Adenosine Link during Myocardial Ischemia—Reperfusion Injury
title_full_unstemmed The Hypoxia-Adenosine Link during Myocardial Ischemia—Reperfusion Injury
title_short The Hypoxia-Adenosine Link during Myocardial Ischemia—Reperfusion Injury
title_sort hypoxia adenosine link during myocardial ischemia reperfusion injury
topic adenosine
hypoxia
CD73
CD39
Adora2a
A2A
url https://www.mdpi.com/2227-9059/10/8/1939
work_keys_str_mv AT weiruan thehypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT xinxinma thehypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT inhyukbang thehypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT yafenliang thehypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT jochendanielmuehlschlegel thehypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT kuangleitsai thehypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT tingtingwmills thehypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT xiaoyiyuan thehypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT holgerkeltzschig thehypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT weiruan hypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT xinxinma hypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT inhyukbang hypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT yafenliang hypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT jochendanielmuehlschlegel hypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT kuangleitsai hypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT tingtingwmills hypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT xiaoyiyuan hypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury
AT holgerkeltzschig hypoxiaadenosinelinkduringmyocardialischemiareperfusioninjury